Exploring the Nature, Assessment and Treatment of Stuttering

June 20, 2023 updated by: University of Texas at Austin

The Blank Center CARE Model™: An Anti-Ableist Approach to Treatment

The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.

Study Overview

Detailed Description

Stuttering is a neurophysiological communication disorder characterized by a disruption in the forward flow of speech. Stuttering is multifactorial in nature, meaning there are several factors that likely to contribute to the development of stuttering in children and persistence of stuttering into adulthood. About 1% of the worldwide population stutters. In the United States, over 3 million people stutter. Research suggests people who stutter present with negative cognitive and affective components of the disorder, and that the general population holds negative perceptions of stuttering. Historically, people who stutter spend thousands of dollars on treatment that is not effective in mitigating the negative impact of stuttering on their overall communication and quality of life.

Speech-language pathologists evaluate and treat persons who stutter across the lifespan. Research suggests speech-language pathologists report fluency disorders (stuttering and cluttering) as the communication disorders with which they feel least competent and comfortable.

Thus, the purposes of this study are to 1) investigate potential speech, language, psychosocial, and motor contributions to stuttered speech production in monolingual and multilingual speakers and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training tools specific to fluency disorders.

Study Type

Interventional

Enrollment (Estimated)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

A participant will be considered a child who stutters (ages 2-17 years) if

  • their parent/caregiver reports concern that their child is a person who stutters,
  • they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
  • they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).

A participant will be considered an adult who stutters (18+ years) if

  • they report they are a person who stutters,
  • they have received a formal diagnosis of stuttering from a certified speech-language pathologist,
  • they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
  • they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).

Exclusion Criteria:

• There are no exclusion criteria for persons who stutter.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blank Center CARE Model (Communication, Advocacy, Resilience, Education)
The over-arching goal of the Blank Center CARE Model is to ensure individuals who stutter communicate effectively, advocate for themselves in a manner that maintains agency, and ensure their quality of life does not depend on producing, or attempting to control, stuttered speech.
Other Names:
  • Communication-Centered Treatment (CCT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Communication Competence
Time Frame: 11-weeks
psychometric measures of communication competence (e.g., CARE Assessment: Communication Subscale)
11-weeks
Advocacy
Time Frame: 11-weeks
psychometric measures of self-advocacy (e.g., CARE Assessment: Advocacy Subscale)
11-weeks
Resilience
Time Frame: 11-weeks
psychometric measures of resilience (e.g., CARE Assessment: Resilience Subscale)
11-weeks
Education
Time Frame: 11-weeks
psychometric measures of education about stuttering (e.g., CARE Assessment: Education Subscale)
11-weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Courtney T Byrd, PhD, The University of Texas at Austin

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 22, 2015

Primary Completion (Estimated)

May 22, 2035

Study Completion (Estimated)

May 22, 2035

Study Registration Dates

First Submitted

May 30, 2023

First Submitted That Met QC Criteria

June 8, 2023

First Posted (Actual)

June 18, 2023

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 20, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stuttering

Clinical Trials on The Blank Center CARE Model(TM) for Individuals who Stutter

Subscribe